Skip to content
Thursday, June 11, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • Rosner’s Domain | Can Israel’s Image Be Fixed? June 10, 2026
  • FBI charges 8 tied to U of Michigan pro-Palestinian movement with threatening officials, Jewish federation June 10, 2026
  • Spain reports 86% rise in antisemitic incidents, as interior minister takes aim at ‘xenophobia’ June 10, 2026
  • Trump is imagining an Israel after Netanyahu. So are many Israelis. Netanyahu isn’t biting. June 10, 2026
  • This Israeli filmmaker harshly criticizes his country. Pro-Palestinian activists boycotted him anyway. June 10, 2026
  • For many Jewish New Yorkers, the Knicks’ championship run offers a respite from division June 10, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.